Search results
Investors, worried they can’t beat lawmakers in stock market, copy them instead
Washington Post· 4 days agoWatchdog groups have long believed that some lawmakers use that information to make money in the ...
‘Just start over’: Valley View residents rebuild after deadly North Texas tornado
Denton Record-Chronicle· 13 hours agoJoe Baker was at home in Sanger on May 25 when a little before 10 p.m., his wife told him a hail...
Why Is Pinterest (PINS) Up 4.1% Since Last Earnings Report?
Zacks via Yahoo Finance· 5 days agoVGM Scores Currently, Pinterest has a great Growth Score of A, though it is lagging a lot on the...
Insider Sale: Chief Product Officer Sabrina Ellis Sells 22,345 Shares of Pinterest Inc (PINS)
GuruFocus.com via Yahoo Finance· 6 days agoOver the past year, Sabrina Ellis has sold a total of 120,957 shares of Pinterest Inc and has not...
Pin Up Betty Makes it Two in a Row in Regret
Bloodhorse· 3 days agoIt took Three Diamonds Farm's homebred Pin Up Betty eight starts to break her maiden, but it only took one to become a graded stakes winner. filly...
London stocks open lower as US yield spike renews rate worries
Reuters· 7 days agoLondon stocks opened lower on Wednesday after higher U.S. bond yields pressured equities globally,...
2 Stocks Down 54% and 77% to Buy Right Now | The Motley Fool
The Motley Fool· 19 hours agoThe tech bear market of 2022 may be a distant memory now as the Nasdaq Composite has been setting...
Everything You Need for the Perfect July 4th Party
Town & Country via Yahoo News· 7 hours agoNo problem. This easy to light can makes it easy to set up for s'mores no matter where this Independence Day takes you. Portable Campfire amazon.com...
Creighton basketball's Trey Alexander to remain in the NBA draft
Omaha World-Herald· 7 days agoBarring a last-second change ahead of Wednesday night’s deadline, Creighton guard Trey Alexander...
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Zacks via Yahoo Finance· 1 day agoGlaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results...